These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35452214)
21. Codelivery of anti-cancer agents via double-walled polymeric microparticles/injectable hydrogel: A promising approach for treatment of triple negative breast cancer. Davoodi P; Ng WC; Srinivasan MP; Wang CH Biotechnol Bioeng; 2017 Dec; 114(12):2931-2946. PubMed ID: 28832946 [TBL] [Abstract][Full Text] [Related]
22. Skillfully collaborating chemosynthesis with GOx-enabled tumor survival microenvironment deteriorating strategy for amplified chemotherapy and enhanced tumor ablation. Lu R; Zhou L; Liu Q; Wang S; Yang C; Hai L; Guo L; Wu Y Biomater Sci; 2021 Mar; 9(5):1855-1871. PubMed ID: 33464244 [TBL] [Abstract][Full Text] [Related]
23. Novel Water-Borne Polyurethane Nanomicelles for Cancer Chemotherapy: Higher Efficiency of Folate Receptors Than TRAIL Receptors in a Cancerous Balb/C Mouse Model. Ajorlou E; Khosroushahi AY; Yeganeh H Pharm Res; 2016 Jun; 33(6):1426-39. PubMed ID: 26908046 [TBL] [Abstract][Full Text] [Related]
24. Anti-tumor activity of folate targeted biodegradable polymer-paclitaxel conjugate micelles on EMT-6 breast cancer model. Wu D; Zheng Y; Hu X; Fan Z; Jing X Mater Sci Eng C Mater Biol Appl; 2015 Aug; 53():68-75. PubMed ID: 26042692 [TBL] [Abstract][Full Text] [Related]
25. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. Wang Y; Yu L; Han L; Sha X; Fang X Int J Pharm; 2007 Jun; 337(1-2):63-73. PubMed ID: 17289311 [TBL] [Abstract][Full Text] [Related]
26. Folic Acid and Poly(ethylene glycol) Decorated Paclitaxel Nanocrystals Exhibit Enhanced Stability and Breast Cancer-Targeting Capability. Zhao J; Du J; Wang J; An N; Zhou K; Hu X; Dong Z; Liu Y ACS Appl Mater Interfaces; 2021 Mar; 13(12):14577-14586. PubMed ID: 33728919 [TBL] [Abstract][Full Text] [Related]
27. Synergistic enhancement of apoptosis by coralyne and paclitaxel in combination on MDA-MB-231 a triple-negative breast cancer cell line. Kumari S; Mohan MG; Shailender G; Badana AK; Malla RR J Cell Biochem; 2019 Oct; 120(10):18104-18116. PubMed ID: 31172606 [TBL] [Abstract][Full Text] [Related]
28. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma. Zhu D; Wu S; Hu C; Chen Z; Wang H; Fan F; Qin Y; Wang C; Sun H; Leng X; Kong D; Zhang L Acta Biomater; 2017 Aug; 58():399-412. PubMed ID: 28627436 [TBL] [Abstract][Full Text] [Related]
29. Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier. Vinothini K; Rajendran NK; Ramu A; Elumalai N; Rajan M Biomed Pharmacother; 2019 Feb; 110():906-917. PubMed ID: 30572195 [TBL] [Abstract][Full Text] [Related]
30. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors. Ye J; Liu Y; Xia X; Meng L; Dong W; Wang R; Fu Z; Liu H; Han R Oncol Rep; 2016 Jul; 36(1):399-409. PubMed ID: 27175803 [TBL] [Abstract][Full Text] [Related]
31. Folate-polyethyleneimine functionalized mesoporous carbon nanoparticles for enhancing oral bioavailability of paclitaxel. Wan L; Wang X; Zhu W; Zhang C; Song A; Sun C; Jiang T; Wang S Int J Pharm; 2015 Apr; 484(1-2):207-17. PubMed ID: 25724138 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Biological Activity of Folic Acid-Modified Paclitaxel-Loaded Gold Nanoparticles. Ren B; Cai ZC; Zhao XJ; Li LS; Zhao MX Int J Nanomedicine; 2021; 16():7023-7033. PubMed ID: 34703225 [TBL] [Abstract][Full Text] [Related]
33. Promoting Oxidative Stress in Cancer Starvation Therapy by Site-Specific Startup of Hyaluronic Acid-Enveloped Dual-Catalytic Nanoreactors. Yao Z; Zhang B; Liang T; Ding J; Min Q; Zhu JJ ACS Appl Mater Interfaces; 2019 May; 11(21):18995-19005. PubMed ID: 31058483 [TBL] [Abstract][Full Text] [Related]
34. Bradykinin-Potentiating Peptide-Paclitaxel Conjugate Directed at Ectopically Expressed Angiotensin-Converting Enzyme in Triple-Negative Breast Cancer. Guo XM; Yadav MB; Khan M; Hao CW; Lin CY; Huang T; Wu J; Fan BM; Bian ZX J Med Chem; 2021 Dec; 64(23):17051-17062. PubMed ID: 34699215 [TBL] [Abstract][Full Text] [Related]
35. Paclitaxel-loaded tumor cell-derived microparticles improve radiotherapy efficacy in triple-negative breast cancer by enhancing cell killing and stimulating immunity. Hu X; Yu L; Bian Y; Zeng X; Luo S; Wen Q; Chen P Int J Pharm; 2023 Feb; 632():122560. PubMed ID: 36586632 [TBL] [Abstract][Full Text] [Related]
36. Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer. Chen SH; Liu TI; Chuang CL; Chen HH; Chiang WH; Chiu HC J Mater Chem B; 2020 May; 8(17):3789-3800. PubMed ID: 32150202 [TBL] [Abstract][Full Text] [Related]
37. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance. Wang F; Zhang D; Zhang Q; Chen Y; Zheng D; Hao L; Duan C; Jia L; Liu G; Liu Y Biomaterials; 2011 Dec; 32(35):9444-56. PubMed ID: 21903258 [TBL] [Abstract][Full Text] [Related]
38. Folic Acid-Functionalized Nanomedicine: Folic Acid Conjugated Copolymer and Folate Receptor Interactions Disrupt Receptor Functionality Resulting in Dual Therapeutic Anti-Cancer Potential in Breast and Prostate Cancer. DeCarlo A; Malardier-Jugroot C; Szewczuk MR Bioconjug Chem; 2021 Mar; 32(3):512-522. PubMed ID: 33556240 [TBL] [Abstract][Full Text] [Related]
39. Paclitaxel/sunitinib-loaded micelles promote an antitumor response in vitro through synergistic immunogenic cell death for triple-negative breast cancer. Qin T; Xu X; Zhang Z; Li J; You X; Guo H; Sun H; Liu M; Dai Z; Zhu H Nanotechnology; 2020 Sep; 31(36):365101. PubMed ID: 32434167 [TBL] [Abstract][Full Text] [Related]
40. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia. Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]